Description: Galderma Group AG operates as a dermatology company worldwide. The company delivers a science-based portfolio of brands and services that span the spectrum of the dermatology market, including injectable aesthetics, dermatological skincare, and therapeutic dermatology. Its portfolio of flagship brands includes Dysport/Azzalure, Alluzience, Restylane, and Sculptra in injectable aesthetics; Cetaphil and Alastin in dermatological skincare; and Soolantra, Epiduo, Differin, Aklief, Epsolay, Twyneo, Oracea, Metvix, Benzac, and Loceryl in therapeutic dermatology. The company was founded in 1981 and is headquartered in Zug, Switzerland.
Home Page: www.galderma.com
Zählerweg 10
Zug,
6300
Switzerland
Phone:
41 58 455 85 92
Officers
| Name | Title |
|---|---|
| Dr. Flemming Ornskov M.B.A., M.P.H. | CEO & Director |
| Mr. Thomas J. W. Dittrich | Chief Financial Officer |
| Mr. Adrian Murphy | Head of Global Operations |
| Mr. Emil Ivanov | Head of Strategy, Investor Relations & ESG |
| Mr. Christian Marcoux | Chief Communications Officer |
| Ms. Allison Pinkham | Chief Human Resources Officer |
Exchange: OTCGREY
Country: US : United States of America
Currency: US Dollar ($)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0 |
| Price-to-Sales TTM: | 0 |
| IPO Date: | |
| Fiscal Year End: | |
| Full Time Employees: | 6545 |